Furthermore, by overlapping these three algorithms, we developed 5 shared biomarkers (CHST11, GLIPR1, SLC16A6, MAMLD1, HAPLN1, GAS1) for the PCOS group (Figures 5D, I). This evidence concerns the gene MAMLD1 and polycystic ovary syndrome.